EVK.DE · Intrinsic value
Is Evonik Industries AG (EVK.DE) overvalued or undervalued?
As of Oct 19, 2026, TickerWorth's valuation lenses put Evonik Industries AG (EVK.DE) at €17.85 – €59.63, too broad a range to say where the delayed market price of €21.34 sits in it, so we do not call it over- or undervalued. It is a model estimate, and every input behind it is sourced below.
Model by Miraaj Patel · generated from market data · Updated Oct 19, 2026 · How these pages are made
What is EVK.DE worth?
- Fair-value range
- €17.85 – €59.63
- Market price
- €21.34
- Gap to fair value
- —
- Verdict
- Too wide to call
Reverse DCF: Today's price implies revenue growth of 8.4% a year for 5 years; our model assumes 7.6% a year on average over the same horizon.
What is EVK.DE's TickerWorth Score?
Cheap against our estimate — but a weaker business
Compared with Basic Materials companies in Europe
Its strongest point: looks cheap on the numbers. Its weakest: profitability is weak.
- Value · 68 of 100
Cheaper than 68% of Basic Materials companies in Europe
- Price vs worth · 75 of 100
- Quality · 13 of 100
More profitable than 13% of Basic Materials companies in Europe
- Financial health · 51 of 100
Financially stronger than 51% of Basic Materials companies in Europe
- Growth · 70 of 100
Growing faster than 70% of Basic Materials companies in Europe
- Momentum · 88 of 100
Outperformed 88% of Basic Materials companies in Europe over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
Why EVK.DE gets a range, not one number
At a recent price of €21.34, Evonik Industries AG (EVK.DE) sits inside a range too wide to call either way: our valuation lenses put the business somewhere between €17.85 and €59.63 per share. They disagree too widely for us to state a single fair value. We publish the range rather than a midpoint because a number that precise would claim more than the methods can support. This is an educational model, not a price target or a recommendation.
Read the full reasoning
The valuation discounts Evonik Industries AG's projected free cash flows at a weighted-average cost of capital (WACC) of 7.2%, with a long-run terminal growth rate of 2.5%. About 81% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.
Running the DCF in reverse — solving for the growth the current price already assumes — the market is implying roughly 8.4% annual revenue growth for EVK.DE. Our base case instead compounds to about 7.6% a year over the same forecast, so the market's implied growth is broadly in line with our base case. The reverse-DCF is a quick sanity check: it reframes 'is this stock cheap?' as 'do I believe the growth the price requires?' rather than arguing over a single point estimate of fair value.
Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, EVK.DE's modeled DCF value ranges from about €10.19 to €48.05 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.
How to read this page: the DCF fair value is what Evonik Industries AG would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of EVK.DE's intrinsic value. Figures update as new filings and prices come in.
Every input behind EVK.DE's DCF
| Input | Value |
|---|---|
| Base-year revenueLive feed — totalRevenue (TTM) | €14,112,000,000 |
| Base EBIT marginComputed — trailing operatingMargins, held roughly flat | 4.1% |
| Forecast revenue growthESTIMATEAssumption — TickerWorth's 5-year explicit forecast | 11% → 9% → 8% → 6% → 4% |
| Risk-free rateLive feed — US 10-year Treasury yield (^TNX) | 5.3% |
| BetaLive feed — yfinance, 5-year monthly beta vs the S&P 500 (clamped to 0.4–2.5) | 0.55 |
| Terminal growthESTIMATEAssumption — TickerWorth house default 2.5%, held below WACC | 2.5% |
| Diluted sharesLive feed — sharesOutstanding | 466M |
| Market priceLast known price · as of 2026-10-19 17:50 UTC | €21.34 |
Change EVK.DE's assumptions
The discount-rate dial and the editable model
ProChange growth, margin and WACC yourself — Pro (7-day free trial, card required).
What does Evonik Industries AG do?
What does it do?
Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. It operates in the Specialty Chemicals industry (Basic Materials sector), headquartered in Germany. The company employs roughly 30,356 people.
How does it make money?
The business turns 14.1B in annual revenue into profit. Out of every $100 of sales, about $4 is left as operating profit (operating margin of 4.1%), after a 25% gross margin on the products/services it sells. After all costs, taxes and interest, 0.9% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks mixed: carries modest debt (0.5× equity), can just cover its short-term bills (1.5× current ratio), and is currently profitable.
EVK.DE insider trading
Insider filings are available for US-listed companies only.
Common questions
What is EVK.DE's intrinsic value?
TickerWorth's valuation lenses put Evonik Industries AG (EVK.DE) between €17.85 and €59.63 per share, versus a market price of €21.34. They disagree too widely for us to state a single fair value, so we publish the range.
Is EVK.DE overvalued or undervalued?
At €21.34 the price sits inside a range too wide to call either way. We don't call EVK.DE overvalued or undervalued from a range this wide. This is an educational estimate, not advice.
What discount rate is used for EVK.DE?
A WACC of 7.2% and a terminal growth rate of 2.5%.
Is Evonik Industries stock undervalued?
TickerWorth's fair-value range for Evonik Industries AG (EVK.DE) is €17.85 – €59.63 against a market price of €21.34. Too wide to call. We publish a range here, not one number, so we do not call it over- or undervalued. This is a model estimate, not investment advice.
Evonik Industries (EVK.DE) DCF valuation and fair value
Our fair-value range for Evonik Industries AG (EVK.DE) is €17.85 – €59.63, built on a 7.2% discount rate (WACC) and 2.5% terminal growth. It blends our discounted-cash-flow model with other valuation lenses. Every assumption is listed on this page with its source.
What growth is priced into Evonik Industries stock?
Today's price implies revenue growth of 8.4% a year for 5 years; our model assumes 7.6% a year on average over the same horizon. This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of €21.34. A model estimate, not investment advice.
Evonik Industries (EVK.DE) insider trading
We have no recent SEC Form 4 insider filings on file for Evonik Industries AG (EVK.DE). Form 4 covers US-listed companies only.
Other ways into the coverage
Not investment advice. TickerWorth Score is a model output.
Educational tool. Every output reflects the assumptions shown — not a prediction and not investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public filings and market data that can be wrong.